Photo of Sakari Kauppinen

Sakari Kauppinen

  • Frederikskaj 10B, C, FK10B-218

    2450 København SV

    Denmark

20102019
If you made any changes in Pure these will be visible here soon.

Research Output 2010 2019

Filter
Patent
2018

Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

Garzon, R., Dorrance, A., Papaioannou, D., Lee, R., Kauppinen, S., Petri, A. & Albæk Thrue, C., 2018, IPC No. C12N 15/ 113 A I, Patent No. WO2018085656, 11 May 2018, Priority date 3 Nov 2016, Priority No. US201662416993P

Research output: Patent

Open Access
Long Noncoding RNA
Untranslated RNA
Disclosure
Acute Myeloid Leukemia

Antisense oligonucleotides (ASOs) designed to inhibit immune checkpoint proteins

Kauppinen, S., Petri, A. & Thrue, C. A., 2018, Patent No. WO2018024849, 8 Feb 2018, Priority date 3 Aug 2016, Priority No. PA201670576

Research output: Patent

Open Access

Therapeutic targeting of a microRNA to treat Duchenne muscular syatrophy

Naar, A. M., Kauppinen, S. & Petri, A., 2018, IPC No. C12N 15/ 113 A I, Patent No. WO2018080658, 3 May 2018, Priority date 23 Jun 2017, Priority No. US201762523923P

Research output: Patent

Open Access
Duchenne Muscular Dystrophy
MicroRNAs
Nucleic Acids
Therapeutics
2017

Antisense oligonucleotides for modulation of long noncoding RNAs

Kauppinen, S., Petri, A. & Thrue, C. A., 2017, Patent No. WO2017211999, 14 Dec 2017, Priority date 8 Jun 2016, Priority No. PA201670413

Research output: Patent

Open Access